CymitQuimica logo
PI3K/Akt/mTOR Signaling

PI3K/Akt/mTOR Signaling

PI3K/Akt/mTOR signaling inhibitors are compounds that target the phosphoinositide 3-kinase (PI3K), Akt kinase, and mammalian target of rapamycin (mTOR) pathways. These pathways are critical regulators of cell growth, survival, metabolism, and autophagy, making them key targets in cancer research and metabolic disorders. Inhibiting these pathways can help to control tumor growth and proliferation, offering potential therapeutic strategies for various cancers and other diseases characterized by dysregulated cell signaling. At CymitQuimica, we offer a comprehensive selection of high-quality PI3K/Akt/mTOR inhibitors to support your research in oncology, cellular signaling, and metabolic diseases.

Subcategories of "PI3K/Akt/mTOR Signaling"

Show 2 more subcategories

Found 1038 products of "PI3K/Akt/mTOR Signaling"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • O-Desmethyl gefitinib

    CAS:
    <p>O-Desmethyl gefitinib is an active EGFR inhibitor (IC50: 36 nM), a metabolite of Gefitinib, formed by CYP2D6.</p>
    Formula:C21H22ClFN4O3
    Purity:97.17%
    Color and Shape:Solid
    Molecular weight:432.88
  • LCH-7749944

    CAS:
    <p>LCH-7749944 suppresses human gastric cancer cell growth, induces apoptosis, and inhibits PAK4 with IC50 of 14.93 μM.</p>
    Formula:C20H22N4O2
    Purity:99.48%
    Color and Shape:Solid
    Molecular weight:350.41
  • NSC781406

    CAS:
    <p>NSC781406 is a highly effective inhibitor of PI3K and mTOR (IC50: 2 nM for PI3Kα).</p>
    Formula:C29H27F2N5O5S2
    Purity:99.58%
    Color and Shape:Solid
    Molecular weight:627.68
  • Petosemtamab

    CAS:
    <p>Petosemtamab (MCLA 158), a dual-action monoclonal antibody targets EGFR &amp; LGR5, used in solid tumor research like HNSCC &amp; CRC.</p>
    Purity:> 95% - > 95%
    Color and Shape:Liquid
    Molecular weight:145.97 kDa
  • GSK-3 inhibitor 4

    CAS:
    <p>Orally active GSK-3 inhibitor 4 targets GSK-3α/β, CDK2/5 (IC50: 0.45-0.68 μM) and may aid in Alzheimer's research by lowering Tau protein.</p>
    Formula:C22H15F2N5O
    Purity:99.41%
    Color and Shape:Soild
    Molecular weight:403.38
  • STL127705

    CAS:
    <p>STL127705 inhibits Ku 70/80 protein &amp; DNA-PKCS kinase, IC50s: 3.5 μM &amp; 2.5 μM.</p>
    Formula:C22H20FN5O4
    Purity:99.53% - 99.81%
    Color and Shape:Solid
    Molecular weight:437.42
  • LTURM34

    CAS:
    <p>LTURM34 is an inhibitor of DNA-PK with IC50 of 34 nM.</p>
    Formula:C24H18N2O3S
    Purity:99.34%
    Color and Shape:Solid
    Molecular weight:414.48
  • Erlotinib hydrochloride

    CAS:
    <p>Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>
    Formula:C22H23N3O4·HCl
    Purity:99.78% - 99.85%
    Color and Shape:White Or Off-White Powder
    Molecular weight:429.9
  • Varlitinib Tosylate

    CAS:
    <p>Varlitinib Tosylate is a selective and potent inhibitor of ErbB1(EGFR) and ErbB2(HER2).</p>
    Formula:C36H35ClN6O8S3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:811.34
  • Anticancer agent 271


    <p>Anticanceragent 271 (compound 5C) exhibits antiproliferative activity against lung cancer (A549), colon cancer (Caco-2) cell lines, and human lung fibroblasts (WI38), with an IC50 value of 9.18 μM for A549 cells. This compound can downregulate PI3K and mTOR gene expression and is applicable in cancer research.</p>
    Color and Shape:Odour Solid
  • RMC-4529

    CAS:
    <p>RMC-4529 is a chemical compound that demonstrates potent inhibition, with an IC50 value of 1.0 nM, against p-4E-BP1-(T37/46) in mTOR kinase cellular assays.</p>
    Formula:C90H139N13O23
    Color and Shape:Solid
    Molecular weight:1771.17
  • IBI-334


    <p>IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.</p>
    Color and Shape:Odour Liquid
  • Duligotuzumab

    CAS:
    <p>Duligotuzumab is a dual-targeting anti-EGFR/HER3 mAb that blocks signaling and induces ADCC for tumors with poor prognosis.</p>
    Purity:95% - 95%
    Color and Shape:Liquid
  • Cetuximab MMAE


    <p>Cetuximab-MMAE, an antibody-drug conjugate (ADC), combines an EGFR-targeting antibody with Monomethyl auristatin E (MMAE) to investigate colorectal and head and neck cancers.</p>
    Color and Shape:Liquid
    Molecular weight:150 kDa
  • YH32367


    <p>YH32367 (ABL105) is a bispecific antibody targeting HER2 and 4-1BB. It induces the secretion of IFN-γ, resulting in the death of tumor cells when co-cultured with hPBMC and HER2-expressing tumor cells. YH32367 demonstrates notable antitumor activity.</p>
    Color and Shape:Odour Liquid
  • Lyso-Monosialoganglioside GM3

    CAS:
    <p>Lyso-Monosialoganglioside GM3 (Lyso-GM3) is an analog of Ganglioside GM3 with antitumor properties. It inhibits the increase in EGFR kinase activity induced by EGF in A431 epithelial cancer cells.</p>
    Formula:C41H74N2O20
    Color and Shape:Solid
    Molecular weight:915.028
  • HER2/neu (654-662) GP2

    CAS:
    <p>Phage display selected Affibody ligands for HER2/neu from a protein library based on a 58-residue Staphylococcal protein A Z domain.</p>
    Formula:C42H77N9O11
    Purity:98%
    Color and Shape:Solid
    Molecular weight:884.11
  • Tephrosin

    CAS:
    <p>Tephrosin induces degradation of of EGFR and ErbB2 by inducing internalization of the receptors, has potent antitumor activities.</p>
    Formula:C23H22O7
    Purity:98%
    Color and Shape:Solid
    Molecular weight:410.42
  • Multi-target kinase inhibitor 4


    <p>Multi-target kinase inhibitor 4 (Compound 2) is a PI3K/DNA-PK inhibitor and a potent chemosensitizer that enhances the number of DNA double-strand breaks induced by Doxorubicin. It serves as an effective multidrug resistance (MDR) inhibitor, demonstrating inhibitory activity against P-glycoprotein (P-gp) mediated drug efflux. Multi-target kinase inhibitor 4 can be encapsulated in PEG-coated lipid nanoparticles.</p>
    Color and Shape:Odour Solid
  • Duvelisib (R enantiomer) hydrochloride


    <p>Duvelisib (R enantiomer) hydrochloride (INK1197 R enantiomer HCl) is a PI3K inhibitor.</p>
    Formula:C22H18Cl2N6O
    Purity:99.88% - >99.99%
    Color and Shape:Soild
    Molecular weight:453.32